Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]

NCT06150040 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped low recruitment rate

Conditions

Acute Myeloid Leukemia Refractory

Interventions

DRUG: NP137
DRUG: Azacitidine Injection
DRUG: Venetoclax

Sponsor

Centre Leon Berard

Collaborators

[object Object]